Wilkerson Advisory Group’s Avanos Medical AVNS Stock Holding History

Wilkerson Advisory Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$224	Hold	9	–	–	﹤0.01%	606
2026 Q1	$126	Hold	9	–	–	﹤0.01%	595
2025 Q4	$101	Buy	+9	New	+$103	﹤0.01%	570

Other funds holding AVNS

Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return

Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return

Tokio Marine Asset Management Tokyo, Japan $3.23B AUM 37.2% 1-Year Est. Return

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS)

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Wilkerson Advisory Group's AVNS Position: Q2 2026 in Review

Wilkerson Advisory Group held its Avanos Medical (AVNS) position steady in Q2 2026 at 9 shares worth $224. The position accounts for ﹤0.01% of the portfolio, ranked #606.

Wilkerson Advisory Group first reported a position in AVNS in Q4 2025 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Wilkerson Advisory Group held 9 shares of Avanos Medical worth $224 as of Q2 2026.
Wilkerson Advisory Group left its Avanos Medical share count unchanged in Q2 2026.
Avanos Medical made up ﹤0.01% of Wilkerson Advisory Group's portfolio in Q2 2026, its #606 holding.
Wilkerson Advisory Group first reported a position in Avanos Medical in Q4 2025 and has held it in 3 quarters since.
78 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Wilkerson Advisory Group's 13F filing for Q2 2026, filed 21 Jul 2026.